Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Board Changes

12 Aug 2021 07:00

RNS Number : 3727I
Norman Broadbent PLC
12 August 2021
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

Board Changes

The board (the "Board") of Norman Broadbent (AIM: NBB), a leading London quoted Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services (Board & Leadership Search, Senior Interim Management, Research & Insight, Leadership Consulting & Assessment, and executive level Talent Solutions), announces that Angela Hickmore will be joining the Board as Non Executive Director effective from today.

Angela joined Norman Broadbent in 2016, and in October 2020 Angela was appointed Group Managing Director, reporting to Group CEO. Prior to joining NBB, Angela was a Partner at Interim Partners /BrightPool for five years and prior to that was Managing Director at Albemarle Interim Management Plc for 10 years. She is one of the leading experts in the Interim Management market.

The Group is currently in the process to find a new CEO. Once appointed, Angela will hand them her existing Executive responsibilities

Peter Searle, Executive Chairman, said: "On behalf of the Board, I would like to welcome Angela to this new role for her within the Company. Her industry expertise and strategic insight will be invaluable as we move into next phase of growth.

Angela Hickmore said: "I'm delighted to be joining the Board. The last five years have flown by and I have enjoyed the challenge of diversifying the service offerings and building the team. I look forward to using this experience in a new capacity on the Board".

AIM disclosures:

Angela Genevieve Hickmore (nee Angela Genevieve Gaffney, aged 58) owns 1,333,333 shares in the Company, representing 2.4% of the issued share capital.

A list of Angela's current directorships and partnerships together with those held within the last five years is set out below:

Current appointments

Appointments in last 5 years

None

Norman Broadbent Interim Management Ltd

 

No further information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

For further information, please contact:

Norman Broadbent plc

Peter Searle

Steve Smith

 

020 7484 0000

WH Ireland Limited

Adrian Hadden

Jessica Cave

Darshan Patel 

 

 

020 7220 1666 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFIESFEFSESA
Date   Source Headline
12th Nov 20212:30 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSAppointment of Group Managing Director
27th Sep 20217:02 amRNSSubscription Results and PDMR Dealing
27th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
12th Aug 20217:00 amRNSBoard Changes
12th Jul 20217:00 amRNSBoard Changes
25th Jun 202112:30 pmRNSResult of AGM
15th Jun 20217:00 amRNSAppointment of Executive Chairman
24th May 20217:00 amRNSFinal Results and Annual Accounts
13th May 202111:59 amRNSHolding(s) in Company
12th May 202112:17 pmRNSHolding(s) in Company
12th May 20219:39 amRNSHolding(s) in Company
19th Apr 202111:59 amRNSNotice of Results
19th Apr 202111:53 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSFY2020 Trading Update
26th Nov 20207:00 amRNSFunding Update
23rd Nov 20204:54 pmRNSHolding(s) in Company
21st Oct 20201:45 pmRNSAppointments - Group Managing Director & Others
16th Oct 20201:00 pmRNSDirector/PDMR Shareholding & Concert Party Update
5th Oct 20203:01 pmRNSIssue of Equity
5th Oct 20207:00 amRNSAcquisition of minority interest in NBIMv
28th Sep 20207:00 amRNSInterim Results
27th Aug 202010:40 amRNSDirectorate Change
24th Aug 202010:59 amRNSDirector/PDMR Shareholding
28th Jul 202010:18 amRNSResult of AGM and Appointment of Chair
28th Jul 20207:00 amRNSAGM Statement and Trading Update
16th Jul 202010:35 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSFinal Results and Annual Accounts
26th May 202011:32 amRNSDirector/PDMR Shareholding
18th May 202012:33 pmRNSDirector/PDMR Shareholding
18th May 20207:00 amRNSTrading Update
11th Mar 202012:00 pmRNSAppointment of CFO & COO
9th Mar 20207:00 amRNSChange of address
3rd Mar 20207:00 amRNSExpansion driven by increased client demand
28th Feb 20207:00 amRNSUpdate: Chief Financial Officer Succession
24th Jan 20207:00 amRNSTrading Update
10th Dec 20197:00 amRNSNorman Broadbent Group partners with UN Women UK
26th Sep 20197:00 amRNSInterim Results for six months ended 30 June 2019
9th Sep 20197:00 amRNSNew and Enhanced Working Capital Facility
23rd Aug 201911:31 amRNSHolding(s) in Company
23rd Aug 201910:51 amRNSShareholder Update and Director/PDMR Shareholding
6th Aug 20194:17 pmRNSDirector/PDMR Shareholding
22nd Jul 201912:46 pmRNSResult of AGM
22nd Jul 20197:00 amRNSAGM Statement - Norman Broadbent returns to profit
28th Jun 20197:00 amRNSFinal Results and Annual Accounts
10th Jun 201910:32 amRNSCEO recognised by CEO Today magazine
27th Mar 20193:29 pmRNSHolding(s) in Company
13th Feb 20197:00 amRNSTrading Update
28th Sep 20187:00 amRNSInterim Results
6th Jun 201811:49 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.